Viewing data from:

DROXIDOPA

ANDA

DROXIDOPA | A211818 | ZYDUS PHARMACEUTICALS USA INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: NORTHERA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 3 NDCs

Highest NADAC/Unit

$1.85

per ea

Lowest NADAC/Unit

$0.4697

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70710139109DROXIDOPA 300 MG CAPSULE	$1.85	EA	Generic	—	2026-10-21
70710139009DROXIDOPA 200 MG CAPSULE	$0.9861	EA	Generic	—	2026-10-21
70710138909DROXIDOPA 100 MG CAPSULE	$0.4697	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

MSN LIFE SCIENCES PRIVATE LTDDROXIDOPA

DMF 315142017

LUPIN MANUFACTURING SOLUTIONS LTDDROXIDOPA

DMF 320322017

DASAMI LAB PRIVATE LTDDROXIDOPA

DMF 321842017

QUIMICA SINTETICA SADROXIDOPA

DMF 322642017

MATRIX PHARMACORP PRIVATE LTDDROXIDOPA

DMF 330892018

CLAROCHEM IRELAND LTDDROXIDOPA

DMF 334592019

PIRAMAL PHARMA LTDDROXIDOPA

DMF 342582019

SUN PHARMACEUTICAL INDUSTRIES LTDDROXIDOPA

DMF 343892019

DASAMI LAB PRIVATE LTDDROXIDOPA (PROCESS-II)

DMF 353682020

SUMITOMO DAINIPPON PHARMA CO LTDInactiveDROXIDOPA

DMF 205562007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 100MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 18, 2021

No patent or exclusivity listings for this strength.

#002 — 200MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 18, 2021

#003 — 300MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 18, 2021